Miratul Muqit has started working in the MRC Unit, after being awarded a prestigious Wellcome Trust Intermediate Clinical Fellowship, to carry out research on the Parkinson's disease associated kinases PINK1 and LRRK2. Miratul is a clinical neurologist who was involved in the original discovery of PINK1 mutations in Parkinson's patients and was attracted to the MRC Protein Phosphorylation Unit in view of the outstanding research environment and facilities for performing cell and molecular biological studies as applied to human disease.
Miratul will be working closely with researchers in Dario Alessi's lab to unravel the functions of PINK1/LRRK2 kinases and will also undertake clinical duties at Ninewells Hospital. He received his medical degree from the University of Edinburgh and his PhD from University College London, and has trained as a neurologist at the National Hospital for Neurology and Neurosurgery in London.
For further details on Miratul's research interests click here.
Miratul will be working closely with researchers in Dario Alessi's lab to unravel the functions of PINK1/LRRK2 kinases and will also undertake clinical duties at Ninewells Hospital. He received his medical degree from the University of Edinburgh and his PhD from University College London, and has trained as a neurologist at the National Hospital for Neurology and Neurosurgery in London.
For further details on Miratul's research interests click here.